WEISMAN HOWARD J. (Chief Executive Officer) reported 1 transaction at KUVATRIS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/14/2024ACC: 0001104659-24-034557
DirectorOfficer· Chief Executive Officer
Since Aug 2022
-2.93K
Net shares
Net seller
$2.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.93K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.93K
Price / share
$0.69
Trade value
$2.02K
% of position
7.8%
3/12/2024
37.67K→34.75K
Total
Net shares
−2.93K
Net value
-$2.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2024 | F · Tax Withholding | −2.93K | $0.69 | $2.02K | 7.8% | 37.67K | 34.75K |
| Total | −2.93K | -$2.02K | ||||||
Derivative Transactions0
No derivative transactions reported